Reports

Sale

Smart Diabetes Management Market

Global Smart Diabetes Management Market Share, Growth, Outlook: By Product Type: Smart Glucose Meters, Continuous Glucose Monitoring Systems, Smart Insulin Pens, Smart Insulin Pumps, Closed Loop Systems, Other; By Device Type; By Applications; By Diseases Type; By End User; Regional Analysis; Supplier Landscape; 2024-2032

Global Smart Diabetes Management Market Outlook

The global smart diabetes management market attained a value of USD 6.04 billion in 2023. The market is further expected to grow in the forecast period of 2024-2032 at a CAGR of 14.75% to reach USD 21.00 billion by 2032.

 

Global Smart Diabetes Management Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America is the leading market in the industry. The smart diabetes management market in the region is being driven by the high presence of key players who have a diversified product portfolio and the early adoption of technologically advanced treatment techniques. With a growing towards among the patients for the self-management of the disease, the market in the region is being further propelled forward. The Asia Pacific and Europe are also significant markets in the industry due to the rising population of the patients afflicted with diabetes in the regions.

 

Market Segmentation

Smart diabetes management help to manage diabetes by increasing patient compliance and helping an individual maintain their blood glucose levels, which is an essential component for controlling diabetes. It contains devices that are integrated with mobile applications via Bluetooth or USB and includes devices like blood glucose monitoring and insulin delivery devices.

 

Global Smart Diabetes Management Market By End Use

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on products, the smart diabetes management market can be divided into:

  • Smart Glucose Meters
  • Continuous Glucose Monitoring Systems
  • Smart Insulin Pens
  • Smart Insulin Pumps
  • Closed Loop Systems

The market can be broadly categorised based on its applications segments as:

  • Type 1 Diabetes 
  • Type 2 Diabetes

Based on its end-use segments, the industry can be divided as:

  • Home Healthcare
  • Hospitals
  • Specialty Diabetes Clinics

The EMR report looks into the regional markets of smart diabetes management like the Asia Pacific, the Middle East and Africa, Europe, Latin America, and North America.

 

Global Smart Diabetes Management Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The market is being driven by the rising prevalence of diabetes and a growing demand for self-diabetes management. The rising innovation and product diversification in the industry is expected to drive the market in the coming years. The increasing demand for smart glucose level monitoring and insulin devices, which are integrated with digital health solutions, is expected to catalyse the industry growth the further. The growing trend of healthcare IT and connected healthcare is expected to propel the industry further forward.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global smart diabetes management market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • F. Hoffmann-La Roche, Ltd.
  • Medtronic plc
  • Dexcom, Inc.
  • Insulet Corporation 
  • Ascensia Diabetes Care Holdings AG
  • Glooko
  • LifeScan IP Holdings, LLC
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • Device Type
  • Applications
  • Diseases Type
  • End User
  • Region
Breakup by Product Type
  • Smart Glucose Meters
  • Continuous Glucose Monitoring Systems
  • Smart Insulin Pens
  • Smart Insulin Pumps
  • Closed Loop Systems
  • Other
Breakup by Device Type
  • Handheld Devices
  • Wearable Devices
Breakup by Applications
  • Diabetes
  • Blood Glucose Tracking
  • Obesity Management
  • Diet Management Apps
  • Others
Breakup by Diseases Type
  • Type 1 Diabetes
  • Type 2 Diabetes
Breakup by End User
  • Hospitals
  • Clinics
  • Home Healthcare
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Abbott Laboratories
  • PHC Holdings Corporation
  • WellDoc, Inc.
  • Sanofi SA
  • Dexcom, Inc.
  • DarioHealth Corp.
  • Medtronic pls
  • B. Braun SE
  • F. Hoffmann-La Roche Ltd.
  • Insulet Corporation
  • Ascensia Diabetes Care Holdings AG
  • Tidepool
  • Tandem Diabetes Care
  • LifeScan
  • AgaMatrix
  • Glooko Inc.
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Smart Diabetes Management Market Overview 

    3.1    Global Smart Diabetes Management Market Historical Value (2017-2023) 
    3.2    Global Smart Diabetes Management Market Forecast Value (2024-2032)
4    Global Smart Diabetes Management Market Landscape
    4.1    Global Smart Diabetes Management Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Smart Diabetes Management Product Landscape
        4.2.1    Analysis by Product Type
        4.2.2    Analysis by Device Type
        4.2.3    Analysis by End User
5    Global Smart Diabetes Management Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Smart Diabetes Management Market Segmentation 
    6.1    Global Smart Diabetes Management Market by Product Type
        6.1.1    Market Overview
        6.1.2    Smart Glucose Meters
        6.1.3    Continuous Glucose Monitoring Systems
        6.1.4    Smart Insulin Pens
        6.1.5    Smart Insulin Pumps
        6.1.6    Closed Loop Systems
        6.1.7    Other
    6.2    Global Smart Diabetes Management Market by Device Type
        6.2.1    Market Overview
        6.2.2    Handheld Devices
        6.2.3    Wearable Devices
    6.3    Global Smart Diabetes Management Market by Applications
        6.3.1    Market Overview
        6.3.2    Diabetes
        6.3.3    Blood Glucose Tracking
        6.3.4    Obesity Management
        6.3.5    Diet Management Apps
        6.3.6    Others
    6.4    Global Smart Diabetes Management Market by Diseases Type
        6.4.2    Type 1 Diabetes
        6.4.3    Type 2 Diabetes
    6.5    Global Smart Diabetes Management Market by End User
        6.5.1    Market Overview
        6.5.2    Hospitals
        6.5.3    Clinics
        6.5.4    Home Healthcare
        6.5.5    Others
    6.6    Global Smart Diabetes Management Market by Region
        6.6.1    Market Overview
        6.6.2    North America 
        6.6.3    Europe
        6.6.4    Asia Pacific
        6.6.5    Latin America
        6.6.6    Middle East and Africa
7    North America Smart Diabetes Management Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Smart Diabetes Management Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Smart Diabetes Management Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Smart Diabetes Management Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Smart Diabetes Management Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    Abbott Laboratories
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    PHC Holdings Corporation
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    WellDoc, Inc.
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Sanofi SA
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Dexcom, Inc.
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    DarioHealth Corp.
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Medtronic pls
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    B. Braun SE
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    F. Hoffmann-La Roche Ltd.
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Insulet Corporation
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
    17.11    Ascensia Diabetes Care Holdings AG
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications
    17.12    Tidepool
        17.12.1    Financial Analysis
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Mergers and Acquisitions
        17.12.5    Certifications
    17.13    Tandem Diabetes Care
        17.13.1    Financial Analysis
        17.13.2    Product Portfolio
        17.13.3    Demographic Reach and Achievements
        17.13.4    Mergers and Acquisitions
        17.13.5    Certifications
    17.14    LifeScan
        17.14.1    Financial Analysis
        17.14.2    Product Portfolio
        17.14.3    Demographic Reach and Achievements
        17.14.4    Mergers and Acquisitions
        17.14.5    Certifications
    17.15    AgaMatrix
        17.15.1    Financial Analysis
        17.15.2    Product Portfolio
        17.15.3    Demographic Reach and Achievements
        17.15.4    Mergers and Acquisitions
        17.15.5    Certifications
    17.16    Glooko Inc.
        17.16.1    Financial Analysis
        17.16.2    Product Portfolio
        17.16.3    Demographic Reach and Achievements
        17.16.4    Mergers and Acquisitions
        17.16.5    Certifications
18    Global Smart Diabetes Management Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

In 2023, the global smart diabetes management market attained a value of nearly USD 6.04 billion.

The market is projected to grow at a CAGR of 14.75% between 2024 and 2032.

The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach USD 21.00 billion by 2032.

The major drivers of the industry include rising prevalence of diabetes, growing demand for self-diabetes management, rising innovation, and product diversification in the industry, and increasing demand for smart glucose level monitoring and insulin devices, which are integrated with digital health solutions.

The growing trend of healthcare IT and connected healthcare is expected to be a key trend guiding the growth of the industry.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest share in the market.

The types of smart diabetes management available are smart glucose meters, continuous glucose monitoring systems, smart insulin pens, smart insulin pumps, and closed loop systems.

Smart diabetes management finds applications as type 1 diabetes and type 2 diabetes.

Smart diabetes management can have different end-uses like home healthcare, hospitals, and specialty diabetes clinics.

The leading players in this market are F. Hoffmann-La Roche, Ltd., Medtronic, Inc., Dexcom, Inc., Insulet Corporation, LifeScan IP Holdings, LLC, Ascensia Diabetes Care Holdings AG, and Glooko, among others.

Analyst Review

The global smart diabetes management market attained a value of USD 6.04 billion in 2023, driven by the rising prevalence of diabetes, growing demand for self-diabetes management, rising innovation and product diversification in the industry and increasing demand for smart glucose level monitoring and insulin devices, which are integrated with digital health solutions. Aided by the growing trend of healthcare IT and connected healthcare, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 14.75%. The market is projected to reach USD 21.00 billion by 2032.

EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. Based on the products, the smart diabetes management market can be segmented into smart glucose meters, continuous glucose monitoring systems, smart insulin pens, smart insulin pumps, and closed loop systems. By application, the industry can be divided into type 1 diabetes and type 2 diabetes. Smart diabetes management can have different end-uses like home healthcare, hospitals, and specialty diabetes clinics. The major regional markets for smart diabetes management are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest share of the market. The key players in the above industry include F. Hoffmann-La Roche, Ltd., Medtronic, Inc., Dexcom, Inc., Insulet Corporation, LifeScan IP Holdings, LLC, Ascensia Diabetes Care Holdings AG, and Glooko, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER